Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000950170-25-057630·CARGO Therapeutics, Inc.
Schedule 13G ownership disclosure
N/A
Common Stock, $0.001 par value per share · CUSIP: 14179K101
Event date: 2025-04-23
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Perceptive Advisors LLC
Shares: 1,170,810 · Class: 2.5%
- Joseph Edelman
Shares: 1,170,810 · Class: 2.5%
- Perceptive Life Sciences Master Fund, Ltd.
Shares: 0 · Class: 0.0%
- Perceptive Xontogeny Venture Fund II, L.P.
Shares: 1,170,810 · Class: 2.5%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-057630
- Form type
- SCHEDULE 13G/A
- Filer
- CARGO Therapeutics, Inc.
- CIK
- CIK 1966494
- Filed
- Apr 23, 2025
- Reporting period
- Apr 23, 2025
- Description
- Schedule 13G beneficial ownership